USA    |    Global :  English    简中    繁中    |    MAP
  Login    |     Shopping Cart
 
Technical Support
  Product Support
    Technical Information
    Protocols
    Technical Tips
    FAQs
    Troubleshooting
  Documents
  Publications
  Contact Support
 
  Publications

GENERAL REFERENCES:

01

Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Wangsa D, Heselmeyer-Haddad K, Ried T, et al. Am J Pathol. 2009 Dec;175(6): 2637-2645.

02

Detection of Genomic Amplification of the Human Telomerase Gene TERC, a Potential Marker for Triage of Women with HPV-Positive, Abnormal Pap Smears. Andersson S, Sowjanya P, Ried T, et al. Am J Pathol. 2009 Nov;175(5): 1831-1847.

03

Spectral karyotyping analysis of human and mouse chromosomes. Padilla-Nash HM, Barenboim-Stapleton L, Difilippantonio MJ, Ried T. Nature Protocols. 2006;1(6): 3129-3142

04

Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T. Am J Pathol. 2005 Apr;166(4):1229-38.

05

Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T. Am J Pathol. 2003 Oct;163(4): 1405-16.

06

Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. Difilippantonio MJ, Petersen S, Chen HT, Johnson R, Jasin M, Kannar R, Ried T, Nussenzweig A. J Exp Med. 2002 Aug 19;196(4):469-80.

07

Fluorescent in situ hybridization studies in multiple myeloma. Yuregir OO, Sahin FI, Yilmaz Z, Kizilkilic E, Karakus S, Ozdogu H. Hematology. 2009 Apr;14(2):90-4.

08

Specialized Fluorescence In Situ Hybridization (FISH) Techniques for Leukaemia Research. Kearney L, Colman S. Methods Mol Biol. 2009;538:1-14.

09

Fluorescence In Situ Hybridization (FISH)-Application Guide Edited by Thomas Liehr 2008

10

Fluorescence in situ hybridization for prenatal screening of chromosomal aneuploidies. Weise A, Liehr T. Expert Rev Mol Diagn. 2008 Jul;8(4):355-7.

11

Fluorescence in situ hybridization in diagnostic cytology. Halling KC, Kipp BR. Hum Pathol. 2007 Aug;38(8):1137-44.

12

Multiplex-FISH (M-FISH): technique, developments and applications. Kearney L. Cytogenet Genome Res. 2006;114(3-4):189-98.

13

Fluorescent in situ hybridization and array comparative genomic hybridization: complementary techniques for genomic evaluation. Morrison C. Arch Pathol Lab Med. 2006 Jul;130(7):967-74.

14

Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia. Landstrom AP, Tefferi A. Leuk Lymphoma. 2006 Mar;47(3):397-402.

15

Applications of fluorescence in situ hybridization in cytopathology: a review. Oliveira AM, French CA. Acta Cytol. 2005 Nov-Dec;49(6):587-94.

16

Multi-color FISH techniques. Bayani J, Squire J. Curr Protoc Cell Biol. 2004 Oct;Chapter 22:Unit 22.5.

17

Fluorescence in situ Hybridization (FISH). Bayani J, Squire JA. Curr Protoc Cell Biol. 2004 Sep;Chapter 22:Unit 22.4.

18

Diagnosis of microdeletion syndromes by fluorescence in situ hybridization (FISH). Shaffer LG. Curr Protoc Hum Genet. 2001 May;Chapter 8:Unit 8.10

19

Cytogenetics as an aid in the diagnosis of lymphomas. Glassman AB, Hopwood V, Hayes KJ. Ann Clin Lab Sci. 2000 Jan;30(1):72-4.

20

Multicolor spectral karyotyping of human chromosomes. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. Science. 1996 273, 494-497.

 

CITATIONS (incl. references to CytoTest products used in studies)

01

Jesse M Jaso, C Cameron Yin1, Victoria W Lu1, Ming Zhao1, Lynne V Abruzzo, M James You, Yaling Yang, Raja Luthra, L Jeffrey Medeiros and Gary Lu. B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease. Modern Pathology 27(3): 382-9 (2013). http://www.nature.com/doifinder/10.1038/modpathol.2013.149

http://www.ncbi.nlm.nih.gov/pubmed/24030742

02

Lee JCJeng YMSu SYWu CTTsai KSLee CHLin CYCarter JMHuang JWChen SHShih SRMariño-Enríquez AChen CCFolpe ALChang YLLiang CWIdentification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol. 235(4):539-45 (2015). doi: 10.1002/path.4465.

http://www.ncbi.nlm.nih.gov/pubmed/25319834

03

Jen-Chieh Lee, Sheng-Yao Su, Chun A Changou, Rong-Sen Yang, Keh-Sung Tsai, Michael T Collins, Eric S Orwoll, Chung-Yen Lin, Shu-Hwa Chen, Shyang-Rong Shih, Cheng-Han Lee, YoshinaoOda, Steven D Billings, Chien-Feng Li, G Petur Nielsen, Eiichi Konishi, Fredrik Petersson, Thomas O Carpenter, Kesavan Sittampalam, Hsuan-Ying Huang and Andrew L Folpe. Characterization of FN1–FGFR1 and novel FN1–FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Modern Pathology, Jul 22 , 1–12 (2016) [Epub ahead of print]  doi: 10.1038/modpathol.2016.137

http://www.ncbi.nlm.nih.gov/pubmed/27443518

04

Collins, M., et al. Striking Response of Tumor-Induced Osteomalacia to the FGFR Inhibitor NVP-BGJ398. Journal of Bone and Mineral research, LB-SA0035 (2015).

http://meetinglibrary.asco.org/content/168898-176

 

ORIGINAL ARTICLES (authored by CytoTest):

01

Petrovics G, Li H, Stümpel T, Tan SH, Young D, Katta S, Li Q, Ying K, Klocke B, Ravindranath L, Kohaar I, Chen Y, Ribli D, Grote K, Zou H, Cheng J, Dalgard CL, Zhang S, Csabai I, Kagan J, Takeda D, Loda M, Srivastava S, Scherf M, Seifert M, Gaiser T, McLeod DG, Szallasi Z, Ebner R, Werner T, Sesterhenn IA, Freedman M, Dobi A, Srivastava S. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American menEBioMedicine 2(12):1957-64 (2015). doi: 10.1016/j.ebiom.2015.10.028.

http://www.ncbi.nlm.nih.gov/pubmed/26844274

02

Albert Dobi, Gyorgy Petrovics, Hua Li, Shyh-Han Tan, Tanja Stümpel, Denise Young, Shilpa Katta, Qiyuan Li, Kai Ying, Bernward Klocke, Lakshmi Ravindranath, Indu Kohaar, Yongmei Chen, Dezső Ribli, Korbinian Grote, Hau Zou, Joseph Cheng, Clifton L. Dalgard, Shimin Zhang, István Csabai, Jacob Kagan, David Takeda, Massimo Loda, Sudhir Srivastava, Matthias Scherf, Martin Seifert, Timo Gaiser, David G. McLeod, Zoltan Szallasi, Reinhard Ebner, Thomas Werner, Isabell A. Sesterhenn, Matthew Freedman, Shiv Srivastava. LSAMP gene deletion is associated with rapid disease progression in prostate cancer of African American men [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; 2016. Abstract nr 140.

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=4017&sKey=f78afb44-80bf-4b93-ab18-47ce2eee6d54&cKey=1bab1eec-d02f-4fd5-a66e-e4496eeaec84&mKey=1d10d749-4b6a-4ab3-bcd4-f80fb1922267

03

Shyh-Han Tan, Gyorgy Petrovics, Hua Li, Tanja Stümpel, Denise Young, Shilpa Katta, Qiyuan Li, Xiamen, Kai Ying, Bernward Klocke, Lakshmi Ravindranath, Indu Kohaar, Yongmei Chen, Dezso Ribli, Korbinian Grote, Hua Zou, Joseph Cheng, Clifton L. Dalgard, Shimin Zhang, István Csabai, Joseph Kagan, David Takeda, Massimo Loda, Sudhir Srivastava, Matthias Scherf, Martin Seifert, Timo Gaiser, David G. McLeod, Zoltan Szallasi, Reinhard Ebner, Thomas Werner, Isabell A. Sesterhenn, Matthew Freedman, Albert Dobi, Shiv Srivastava.

A Novel Deletion of the LSAMP Gene Locus Associates with Rapid Progression of Prostate Cancer among African American Men

The Journal of Urology, Vol. 195, No. 4S, Supplement, abstract cr. MP-05 (2016).

http://www.jurology.com/article/S0022-5347(16)01567-6/abstract

 

EDITORIAL:

01

Zhaomin Wang. Distinct Genomic Alterations in Prostate Tumors from African American Men. EBioMedicine, November 2015 (http://dx.doi.org/10.1016/j.ebiom.2015.11.032).

http://www.ncbi.nlm.nih.gov/pubmed/26844255

 

 

CytoTest Inc.  |  9430 Key West Avenue, Suite 210, Rockville, MD 20850, USA
Tel:1-855-CYTOTEST  |  +1-202-688-1188  |  sales@cytotest.com

© 2013 CytoTest Inc. All Rights Reserved.
Website Design | Youhome